DE60321026D1 - In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3 - Google Patents
In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3Info
- Publication number
- DE60321026D1 DE60321026D1 DE60321026T DE60321026T DE60321026D1 DE 60321026 D1 DE60321026 D1 DE 60321026D1 DE 60321026 T DE60321026 T DE 60321026T DE 60321026 T DE60321026 T DE 60321026T DE 60321026 D1 DE60321026 D1 DE 60321026D1
- Authority
- DE
- Germany
- Prior art keywords
- oocytes
- vitro
- phosphodiesterase
- hemmer
- cytoplasmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201581 | 2002-10-15 | ||
PCT/DK2003/000703 WO2004035766A2 (en) | 2002-10-15 | 2003-10-15 | In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60321026D1 true DE60321026D1 (de) | 2008-06-26 |
Family
ID=32103846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60321026T Expired - Fee Related DE60321026D1 (de) | 2002-10-15 | 2003-10-15 | In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060051863A1 (de) |
EP (1) | EP1554016B1 (de) |
JP (1) | JP2006502717A (de) |
AT (1) | ATE395102T1 (de) |
AU (1) | AU2003273767A1 (de) |
DE (1) | DE60321026D1 (de) |
WO (1) | WO2004035766A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2548438T3 (en) | 2006-11-08 | 2015-10-19 | Veritas Bio LLC | IN VIVO SUBMITTING DOUBLE-STRENGTH RNA TO A CELL |
CZ302232B6 (cs) * | 2008-07-15 | 2011-01-05 | Ceská zemedelská univerzita v Praze | Zpusob zvýšení vývojové schopnosti rostoucích oocytu inhibicí kalcineurinu |
CN102482644A (zh) * | 2009-05-14 | 2012-05-30 | 阿德莱德研究和创新私人有限公司 | 用于卵母细胞的收集及成熟的方法 |
US10392601B2 (en) | 2014-12-19 | 2019-08-27 | Vrije Universiteit Brussel | In Vitro maturation of a mammalian cumulus oocyte complex |
WO2024024742A1 (ja) * | 2022-07-25 | 2024-02-01 | 国立大学法人京都大学 | 霊長類の胎児卵巣細胞から卵胞を誘導する体外培養法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2678506B1 (fr) * | 1991-07-01 | 2000-03-10 | Claude Ranoux | Procede de fecondation en cycle spontane. |
CA2265495A1 (en) * | 1996-09-13 | 1998-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Non-hormonal method of contraception |
EP1235899B1 (de) * | 1999-11-25 | 2007-03-21 | Novo Nordisk A/S | Behandlung von menschlicher unfruchtbarkeit |
WO2001076360A2 (en) * | 2000-04-06 | 2001-10-18 | Novo Nordisk A/S | Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
-
2003
- 2003-10-15 AU AU2003273767A patent/AU2003273767A1/en not_active Abandoned
- 2003-10-15 AT AT03757724T patent/ATE395102T1/de not_active IP Right Cessation
- 2003-10-15 WO PCT/DK2003/000703 patent/WO2004035766A2/en active IP Right Grant
- 2003-10-15 DE DE60321026T patent/DE60321026D1/de not_active Expired - Fee Related
- 2003-10-15 EP EP03757724A patent/EP1554016B1/de not_active Expired - Lifetime
- 2003-10-15 JP JP2004543981A patent/JP2006502717A/ja active Pending
-
2005
- 2005-04-15 US US11/107,642 patent/US20060051863A1/en not_active Abandoned
-
2008
- 2008-08-12 US US12/228,349 patent/US20080311656A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20080311656A1 (en) | 2008-12-18 |
ATE395102T1 (de) | 2008-05-15 |
WO2004035766A3 (en) | 2004-06-03 |
US20060051863A1 (en) | 2006-03-09 |
EP1554016A2 (de) | 2005-07-20 |
AU2003273767A1 (en) | 2004-05-04 |
WO2004035766A2 (en) | 2004-04-29 |
JP2006502717A (ja) | 2006-01-26 |
EP1554016B1 (de) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE238428T1 (de) | Enantioselective herstellung von pharmazeutisch aktiven sulfoxiden durch bioreduktion | |
DE69722027D1 (de) | Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung | |
DE59805727D1 (de) | Thiazolderivate, verfahren zur herstellung und verwendung | |
EA200201056A1 (ru) | Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств | |
YU83602A (sh) | Derivati fenilglicina | |
ATE72436T1 (de) | 2-(methyl(4-piperidinyl)>-1,2,3,4-tetrahydro-9h pyrido(3,4-b>indolderivate, ihre herstellung und therapeutische verwendung. | |
DE69624500D1 (de) | Barbitursäure-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten | |
DE59808710D1 (de) | Verfahren zur herstellung von 2-(3-pyrazolyl-oxymethylen)nitrobenzolen | |
DE60321026D1 (de) | In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3 | |
BR0109975A (pt) | Método para produzir ansamitocinas | |
ATE293632T1 (de) | Verfahren zur herstellung von alkylverbrückten ligandsystemen und übergangsmetallverbindungen | |
TW200621685A (en) | Hydroxynaphthoic acid hydrazide compound and method for preparing the same | |
FI925801A0 (fi) | Piperidyl-substituerade indoler | |
NO970473D0 (no) | N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika | |
ATE176459T1 (de) | Verfahren zur herstellung von 2-(sustituierten benzoyl)-1,3 cyclohexandionen | |
ATE392413T1 (de) | Verfahren zur herstellung von beta-alaninamiden | |
ATE487701T1 (de) | Verfahren zur herstellung von iminostilbenderivaten | |
ATE324366T1 (de) | Verfahren zur herstellung von 3-pyrrolin-2- carbonsäure-derivaten | |
ATE361272T1 (de) | Verfahren zur herstellung von 3,3- diarylpropylaminen | |
ATE280769T1 (de) | Verfahren zur herstellung von vitronectin- rezeptorantagonisten | |
DK1651754T3 (da) | Myelomcellekultur i transferrinfrit medium med lavt jernindhold | |
DE60134067D1 (de) | Zwischenplatte zum Einsetzen in einem Schneidschlitz | |
ATE513824T1 (de) | Verfahren zur herstellung von isothiocyanato-2,2- difluorbenzo-(1,3)-dioxolen | |
EA200001076A1 (ru) | Способ получения 4-замещенных-1h-индол-3-глиоксамидов | |
DE69916269D1 (de) | Neues verfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |